# Prometra Post-Approval Study

> **NCT01854229** · NA · COMPLETED · sponsor: **Flowonix Medical** · enrollment: 400 (actual)

## Conditions studied

- Chronic Pain
- Cancer Pain
- Intractable Pain
- Back Pain

## Interventions

- **DEVICE:** Prometra Programmable Intrathecal Infusion Pump

## Key facts

- **NCT ID:** NCT01854229
- **Lead sponsor:** Flowonix Medical
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-06-20
- **Primary completion:** 2023-03-15
- **Final completion:** 2023-03-15
- **Target enrollment:** 400 (ACTUAL)
- **Last updated:** 2023-10-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01854229

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01854229, "Prometra Post-Approval Study". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT01854229. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*